Articles

Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes

Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm
Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark; Present address: Novo Nordisk Research Centre Oxford, Oxford, OX3 7FZ
Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen
Division of Pediatric Hematology and Oncology and Stem Cell Transplantation, Helsinki University Hospital and Helsinki University, Helsinki
Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden; Neuropediatric Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm
Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark; Department of Health Technology, Technical University of Denmark, Kgs. Lyngby
Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm
Department of Pediatric Hematology/Oncology, Oslo University Hospital, Oslo, Norway
Department of Pediatrics, Landspitali University Hospital, Reykjavík, Iceland
QIMR Berghofer Medical Research Institute, Brisbane
Kids Cancer Centre, Sydney Children’s Hospital Randwick, Sydney, Australia; School of Clinical Medicine, Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW MEDICINE and HEALTH, UNSW Sydney; Children’s Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney
School of Clinical Medicine, Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW MEDICINE and HEALTH, UNSW Sydney; Children’s Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney
Department of Hematology and Oncology, University of Tartu, Tartu
Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden; Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm
Department of Children and Adolescents, Oulu University Hospital and University of Oulu, PEDEGO Research Unit, Oulu
Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark; Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen
Division of Pediatric Hematology and Oncology and Stem Cell Transplantation, Helsinki University Hospital and Helsinki University, Helsinki
Children’s Hospital, affiliate of Vilnius University Hospital Santaros Klinikos and Vilnius University, Vilnius
Division of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm
Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen
Department of Women’s and Children’s Health, Uppsala University, Uppsala
Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm
Haematologica Early view Mar 31, 2022 https://doi.org/10.3324/haematol.2021.280016